Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
Authors:
- Masayoshi UehataMUMasayoshi Uehata
- Ichiro TamechikaITIchiro Tamechika
- Jeongsin KeelJKJeongsin Keel
- Kimiko NonomuraKNKimiko Nonomura
- Midori MaekawaMMMidori Maekawa
- Shuh NarumiyaSNShuh Narumiya
- 1 May 2000
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 57 (5) , 976-983
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The effects of the selective ROCK inhibitor, Y27632, on ET‐1‐induced hypertrophic response in neonatal rat cardiac myocytes – possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophyFEBS Letters, 1999
- Rho‐kinase in human neutrophils: a role in signalling for myosin light chain phosphorylation and cell migrationFEBS Letters, 1999
- Transformation mediated by RhoA requires activity of ROCK kinasesCurrent Biology, 1999
- The effects of the Rho‐kinase inhibitor Y‐27632 on arachidonic acid‐, GTPγS‐, and phorbol ester‐induced Ca2+‐sensitization of smooth muscleFEBS Letters, 1998
- p160ROCK, a Rho‐associated coiled‐coil forming protein kinase, works downstream of Rho and induces focal adhesionsFEBS Letters, 1997
- A requirement for Rho and Cdc42 during cytokinesis in Xenopus embryosCurrent Biology, 1997
- ROCK‐I and ROCK‐II, two isoforms of Rho‐associated coiled‐coil forming protein serine/threonine kinase in miceFEBS Letters, 1996
- The small GTP‐binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase.The EMBO Journal, 1996
- A novel partner for the GTP‐bound forms of rho and racFEBS Letters, 1995
- Physiological concentrations of purines and pyrimidinesMolecular and Cellular Biochemistry, 1994